.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Quest Diagnostics recently raised its 2026 profit and revenue forecasts. This update reflects a resilient diagnostic testing demand across both routine and advanced clinical categories. Consequently, the New Jersey-based provider reported first-quarter results that surpassed previous Wall Street expectations. Shares rose significantly as investors reacted to the positive financial outlook.
Healthcare providers are currently navigating a phase of post-pandemic normalization. Therefore, many companies lean on hospital laboratory management deals to maintain steady volumes. Quest recorded a 9.4% revenue increase for its largest business segment. Furthermore, organic requisition volumes increased by over 10% during this period. This growth persists even while the industry faces sustained reimbursement pressures and rising labor costs.
Beyond routine screenings, advanced diagnostic tools show substantial market growth. Specifically, blood tests used to identify Alzheimer's disease are gaining significant traction. Also, tests for cardiometabolic and endocrine conditions reported double-digit revenue increases. These trends highlight a growing clinical focus on early detection of chronic conditions. The company expects to continue this momentum throughout the fiscal year.
Q1: Why did Quest Diagnostics raise its 2026 forecast?
The company cited resilient demand for routine diagnostic testing and significant growth in advanced diagnostics as primary drivers for the upgraded outlook.
Q2: Which specialty testing areas showed the most growth?
Quest reported double-digit revenue growth in advanced diagnostics, specifically in blood tests for Alzheimer's, cardiometabolic conditions, and endocrine disorders.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Quest Diagnostics raises 2026 profit and revenue forecasts due to resilient demand for routine diagnostic testing and advanced screening for Alzheimer's....
6 months ago
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today
Recent clinical studies reveal maternal autoantibodies targeting IL-1RA as potential triggers for preterm labor, opening avenues for targeted cytokine therapies. Concurrently, new perioperative findings show inhaled cannabis increases propofol requirements during upper endoscopy compared to oral edible consumption.
Today
In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
